Silverback Therapeutics, Inc. — Form D/A
Silverback Therapeutics, Inc. of SEATTLE, WA, a company, filed a Form D amendment with the SEC on 2017-02-06. The offering totals $60.0M, of which $10.0M was reported sold. Industry: Biotechnology.
Offering
- Filed: 2017-02-06
- Form: D/A
- Accession: 0001671858-17-000002
- Industry: Biotechnology
- Exemptions: 06b
- Total offering: $60.0M
- Amount sold: $10.0M
- Remaining: $50.0M
- Investors: 1
- Date of first sale: 2016-04-01
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-261100
Issuer
- Name: Silverback Therapeutics, Inc.
- CIK: 0001671858
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2016
- Address: 500 FAIRVIEW AVENUE NORTH, SUITE 600, SEATTLE, WA, 98109
- Phone: 206-456-2900
Officers, directors & promoters (18)
| Name | Role | Location |
|---|
| Peter A Thompson | Director | New York, NY |
| Peter A Thompson | Executive Officer | New York, NY |
| Jonathan Root | Director | Aliso Viejo, CA |
| Peter Thompson | Director | Chanhassen, MN |
| Peter Thompson | Executive Officer | Chanhassen, MN |
| Laura Shawver | Director | Del Mar, CA |
| Laura Shawver | Executive Officer | Del Mar, CA |
| Thilo Schroeder | Director | Grand Duchy of Luxembourg, N4 |
| Vickie L Capps | Director | La Jolla, CA |
| Jonathan L Root | Director | SEATTLE, WA |
| Thilo L Schroeder | Director | SEATTLE, WA |
| Scott L Platshon | Director | SEATTLE, WA |
| Robert L Hershberg | Director | SEATTLE, WA |
| Saqib L Islam | Director | SEATTLE, WA |
| Robert Hershberg | Director | Tucker, GA |
| Saqib Islam | Director | Stamford, CT |
| Robert A Hershberg | Director | Seattle, WA |
| Saqib A Islam | Director | Seattle, WA |
Other filings by this issuer (7)
More